132 related articles for article (PubMed ID: 37120095)
1. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
[TBL] [Abstract][Full Text] [Related]
2. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-β
Perrone F; Bjerke M; Hens E; Sieben A; Timmers M; De Roeck A; Vandenberghe R; Sleegers K; Martin JJ; De Deyn PP; Engelborghs S; van der Zee J; Van Broeckhoven C; Cacace R;
Alzheimers Res Ther; 2020 Sep; 12(1):108. PubMed ID: 32917274
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
Maloney JA; Bainbridge T; Gustafson A; Zhang S; Kyauk R; Steiner P; van der Brug M; Liu Y; Ernst JA; Watts RJ; Atwal JK
J Biol Chem; 2014 Nov; 289(45):30990-1000. PubMed ID: 25253696
[TBL] [Abstract][Full Text] [Related]
6. The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.
Kokawa A; Ishihara S; Fujiwara H; Nobuhara M; Iwata M; Ihara Y; Funamoto S
Acta Neuropathol Commun; 2015 Nov; 3():66. PubMed ID: 26531305
[TBL] [Abstract][Full Text] [Related]
7. The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
Guyon A; Rousseau J; Lamothe G; Tremblay JP
PLoS One; 2020; 15(12):e0237122. PubMed ID: 33370284
[TBL] [Abstract][Full Text] [Related]
8. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
9. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.
Kimura A; Hata S; Suzuki T
J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728
[TBL] [Abstract][Full Text] [Related]
10. Heteromers of amyloid precursor protein in cerebrospinal fluid.
Cuchillo-Ibañez I; Lopez-Font I; Boix-Amorós A; Brinkmalm G; Blennow K; Molinuevo JL; Sáez-Valero J
Mol Neurodegener; 2015 Jan; 10():2. PubMed ID: 25573162
[TBL] [Abstract][Full Text] [Related]
11. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
Wang LS; Naj AC; Graham RR; Crane PK; Kunkle BW; Cruchaga C; Murcia JD; Cannon-Albright L; Baldwin CT; Zetterberg H; Blennow K; Kukull WA; Faber KM; Schupf N; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Rogaeva E; ; Lin CF; Dombroski BA; Cantwell LB; Partch A; Valladares O; Hakonarson H; St George-Hyslop P; Green RC; Goate AM; Foroud TM; Carney RM; Larson EB; Behrens TW; Kauwe JS; Haines JL; Farrer LA; Pericak-Vance MA; Mayeux R; Schellenberg GD; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barmada M; Barnes LL; Beach TG; Becker JT; Beecham GW; Beekly D; Bennett DA; Bigio EH; Bird TD; Blacker D; Boeve BF; Bowen JD; Boxer A; Burke JR; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carroll SL; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Demirci FY; Dick M; Dickson DW; Duara R; Ertekin-Taner N; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Graff-Radford NR; Growdon JH; Hamilton RL; Hamilton-Nelson KL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jarvik GP; Jicha GA; Jin LW; Jun G; Jun G; Kamboh MI; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lopez OL; Lunetta KL; Lyketsos CG; Mack WJ; Marson DC; Martin ER; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam WM; Miller BL; Miller CA; Miller JW; Montine TJ; Morris JC; Murrell JR; Olichney JM; Parisi JE; Perry W; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reiman EM; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Tsuang DW; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
JAMA Neurol; 2015 Feb; 72(2):209-16. PubMed ID: 25531812
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
[TBL] [Abstract][Full Text] [Related]
13. Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease.
Tcw J; Goate AM
Cold Spring Harb Perspect Med; 2017 Jun; 7(6):. PubMed ID: 28003277
[TBL] [Abstract][Full Text] [Related]
14. CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.
Dobrowolska JA; Michener MS; Wu G; Patterson BW; Chott R; Ovod V; Pyatkivskyy Y; Wildsmith KR; Kasten T; Mathers P; Dancho M; Lennox C; Smith BE; Gilberto D; McLoughlin D; Holder DJ; Stamford AW; Yarasheski KE; Kennedy ME; Savage MJ; Bateman RJ
J Neurosci; 2014 Jun; 34(24):8336-46. PubMed ID: 24920637
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
[TBL] [Abstract][Full Text] [Related]
16. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Expression of Amyloid Precursor Protein and the Ratio of Secreted Amyloid Beta 42 to Amyloid Beta 40 in SH-SY5Y Cells Stably Transfected with Wild-Type, Single-Mutant and Double-Mutant Forms of the APP Gene for the Study of Alzheimer's Disease Pathology.
Pahrudin Arrozi A; Shukri SNS; Wan Ngah WZ; Mohd Yusof YA; Ahmad Damanhuri MH; Makpol S
Appl Biochem Biotechnol; 2017 Nov; 183(3):853-866. PubMed ID: 28417423
[TBL] [Abstract][Full Text] [Related]
18. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
[TBL] [Abstract][Full Text] [Related]
19. Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.
Chaves RS; Tran M; Holder AR; Balcer AM; Dickey AM; Roberts EA; Bober BG; Gutierrez E; Head BP; Groisman A; Goldstein LSB; Almenar-Queralt A; Shah SB
J Neurosci; 2021 Dec; 41(49):10034-10053. PubMed ID: 34663629
[TBL] [Abstract][Full Text] [Related]
20. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
